CD4 and rheumatoid arthritis: Decreased IL-10 in the risk group in combination with increased IL-17 secretion from CD4+T cells in RA patients on in vitro stimulation of PBMC, was together with the LN findings interpreted as a shift in the immunoregulatory balance already in the risk phase.125